FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q3 EPS of ($0.26), $0.01 better than the analyst estimate of ($0.27).
For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.
... More
